Strategies to Overcome Antileishmanial Drugs Unresponsiveness
In the absence of effective vector control measures and vaccines against leishmaniasis, effective chemotherapy remains the mainstay of treatment. As the armoury of antileishmanial drugs is limited, strategies should be made to target the emergence of drug resistance. The loss of efficacy of antimoni...
Saved in:
Main Authors: | Shyam Sundar, Anup Singh, Om Prakash Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Journal of Tropical Medicine |
Online Access: | http://dx.doi.org/10.1155/2014/646932 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Developments in Diagnosis and Antileishmanial Drugs
by: Prachi Bhargava, et al.
Published: (2012-01-01) -
2-Aminothiophene Derivatives—New Drug Candidates Against Leishmaniasis: Drug Design, Synthesis, Pharmacomodulation, and Antileishmanial Activity
by: Rodrigo Santos Aquino de Araújo, et al.
Published: (2025-01-01) -
Synthesis and Antileishmanial Activity of Lipophilic Aromatic Aminoalcohols
by: Roberta Novaes Reis Corrales, et al.
Published: (2010-01-01) -
When Should Naloxone Be Administered to the Undifferentiated Unresponsive Person?
Published: (2018-08-01) -
Antileishmanial Activity of Aldonamides and N-Acyl-Diamine Derivatives
by: Elaine S. Coimbra, et al.
Published: (2008-01-01)